ATE392207T1 - Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren - Google Patents

Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren

Info

Publication number: ATE392207T1
Authority: AT; Austria
Prior art keywords: composition; procedures; patients; mmol; blood glucose
Prior art date: 2002-09-13

Application number

AT03795536T

Other languages

English (en)

Inventor

Mats Lake

Ulf Smith

Mette Axelsen

Eva Olausson

Original Assignee

Metcon Medicin Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-13

Filing date

2003-09-12

Publication date

2008-05-15

2002-09-13 Priority claimed from SE0202723A external-priority patent/SE0202723D0/xx

2003-09-12 Application filed by Metcon Medicin Ab filed Critical Metcon Medicin Ab

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE392207T1 publication Critical patent/ATE392207T1/de

Links

238000000034 method Methods 0.000 title abstract 7
239000000203 mixture Substances 0.000 title abstract 5
210000001072 colon Anatomy 0.000 title 1
150000001720 carbohydrates Chemical class 0.000 abstract 3
235000014633 carbohydrates Nutrition 0.000 abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
239000008103 glucose Substances 0.000 abstract 2
230000000968 intestinal effect Effects 0.000 abstract 2
229920002261 Corn starch Polymers 0.000 abstract 1
208000013016 Hypoglycemia Diseases 0.000 abstract 1
208000002720 Malnutrition Diseases 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
239000008120 corn starch Substances 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
235000012054 meals Nutrition 0.000 abstract 1
231100001078 no known side-effect Toxicity 0.000 abstract 1
235000018343 nutrient deficiency Nutrition 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1
230000036642 wellbeing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Detergent Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT03795536T 2002-09-13 2003-09-12 Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren ATE392207T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0202723A SE0202723D0 (sv)	2002-09-13	2002-09-13	Composition and method for use in intestinal cleansing procedures
US42532002P	2002-11-12	2002-11-12

Publications (1)

Publication Number	Publication Date
ATE392207T1 true ATE392207T1 (de)	2008-05-15

Family

ID=31996343

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03795536T ATE392207T1 (de)	2002-09-13	2003-09-12	Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren

Country Status (7)

Country	Link
US (1)	US20050054611A1 (de)
EP (1)	EP1545563B1 (de)
JP (1)	JP2006506349A (de)
AT (1)	ATE392207T1 (de)
AU (1)	AU2003259006A1 (de)
DE (1)	DE60320429D1 (de)
WO (1)	WO2004024168A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2438077B1 (de) *	2009-06-03	2013-12-04	Aptalis Pharma U.S. Inc.	L-zucker als kolonreinigungsmittel und anwendungen davon
JP5910501B2 (ja) *	2010-10-08	2016-04-27	味の素株式会社	Ｃｔコロノグラフィに用いられる経口投与用液剤及び消化管造影用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1414121A (en) *	1971-09-15	1975-11-19	Smith W J	Antacid composition and its preparation
DE3705874A1 (de) *	1987-02-24	1988-09-01	Laevosan Gmbh & Co Kg	Darmspuelloesung
NZ230763A (en) *	1988-09-27	1991-10-25	Takeda Chemical Industries Ltd	Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
CA2007387C (en) *	1990-01-09	1996-06-11	Isami Kimura	Bowel lavage composition
SE469775B (sv) *	1990-12-21	1993-09-13	Ljungqvist Olle Medical Ab	Dryck för preoperativ tillförsel innehållande en kolhydratblandning och användning av sackarider för framställning av drycken
IL112967A0 (en) *	1994-03-15	1995-06-29	Los Angeles Childrens Hospital	Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
GB2311882B (en) *	1996-04-04	2000-08-09	Videologic Ltd	A data processing management system
AU731016B2 (en) *	1996-11-13	2001-03-22	C.B. Fleet Company Incorporated	A coated sodium phosphate bowel cleanser
US6162464A (en) *	1997-03-31	2000-12-19	Inkine Pharmaceutical, Inc.	Non-aqueous colonic purgative formulations
JPH11332514A (ja) *	1998-05-22	1999-12-07	Nof Corp	バランス栄養食品
US6534487B1 (en) *	1999-08-03	2003-03-18	Childrens Hospital Los Angeles	Methods for suppressing appetite and enhancing exercise and recovery
US6316427B1 (en) *	2000-04-04	2001-11-13	Metcon Medicin Ab	Treatment for diabetes
WO2002034271A1 (en) *	2000-10-25	2002-05-02	Metcon Medicin Ab	New composition and method for the treatment of dysglucaemia

2003
- 2003-09-12 JP JP2004535334A patent/JP2006506349A/ja active Pending
- 2003-09-12 EP EP03795536A patent/EP1545563B1/de not_active Expired - Lifetime
- 2003-09-12 AT AT03795536T patent/ATE392207T1/de not_active IP Right Cessation
- 2003-09-12 US US10/496,901 patent/US20050054611A1/en not_active Abandoned
- 2003-09-12 WO PCT/SE2003/001428 patent/WO2004024168A1/en not_active Ceased
- 2003-09-12 DE DE60320429T patent/DE60320429D1/de not_active Expired - Lifetime
- 2003-09-12 AU AU2003259006A patent/AU2003259006A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003259006A1 (en)	2004-04-30
WO2004024168A8 (en)	2004-12-09
DE60320429D1 (de)	2008-05-29
EP1545563A1 (de)	2005-06-29
US20050054611A1 (en)	2005-03-10
EP1545563B1 (de)	2008-04-16
JP2006506349A (ja)	2006-02-23
WO2004024168A1 (en)	2004-03-25

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
Rosen et al.	1999	The aging skeleton
WO2007038623A3 (en)	2009-04-09	Oral formulation for enteric disorders and/or rehydration
CN103005057A (zh)	2013-04-03	一种降血糖的保健茶及制备方法
JPH0678235B2 (ja)	1994-10-05	胃腸粘膜組織障害疾患治療剤
JPH1095732A (ja)	1998-04-14	グリセロリン酸脱水素酵素阻害剤
Keys et al.	1945	Experimental starvation in man
WO2001089537A3 (en)	2002-08-01	Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
ATE392207T1 (de)	2008-05-15	Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren
CN107594520A (zh)	2018-01-19	一种供痛风患者食用的配方食品
WO2004060316A3 (en)	2005-04-21	Irs modulators
Kolls et al.	1924	Contributions to the pharmacology of extracts of the posterior lobe of the pituitary gland
CN105941562A (zh)	2016-09-21	一种防治高血糖的保健饼干
JP5158779B2 (ja)	2013-03-06	Ｄ−アロースを有効成分とする血圧上昇抑制剤
RU2058136C1 (ru)	1996-04-20	Способ лечения аллергических дерматозов
WO2003011119A3 (en)	2003-10-09	Methods and compositions for diagnosis and treatment of vascular conditions
JP3946239B1 (ja)	2007-07-18	加速度脈波加齢指数上昇剤
Prentice	1923	Cancer among negroes
Yeomans et al.	1945	Azotemia in typhus fever
CN107212368A (zh)	2017-09-29	一种降低血糖保健食品及其制备方法
Shilpa et al.	2020	Effectiveness of Lemon juice on reduction of blood pressure among hypertensive clients in selected rural community, Mangaluru
Markova et al.	2003	The state of hemodynamics and microcirculation in patients with hypertensive disease during long term controlled therapy with lisinopril
RU2262926C1 (ru)	2005-10-27	Способ лечения диабетической ангио-ретинопатии
CN107865098A (zh)	2018-04-03	一种益智健康的荞麦奶粉
PRESKORN	1996	Have You Phenotyped Your Patient Lately?
Robb-Nicholson	2002	By the way, doctor. A few months ago, I was surprised to read that a new study has raised a question about the value of screening mammograms. Is that true? I thought the importance of having such mammograms was well-established. I'm 52 and have been getting annual mammograms for 10 years. Should I stop?